Work

Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.3_suppl.tps227

Authors: Aparna Raj Parikh, Vedran Radojcic, Myles Clancy, Susan Brouwer, Shaliny Kushwaha, Yifan Huang, Nashat Gabrail

Institutions: Massachusetts General Hospital, Syndax Pharmaceuticals (United States), Gabrail Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Syndax Pharmaceuticals

OpenAlex ID: W4391095461

Cites:

Cited by: 1

Related to: 10